Axel Bouchon leads the Bayer Lifescience Center, an R&D unit that focuses on new, cross-divisional technologies with fundamental breakthrough potential. He is also a member of the Bayer R&D Executive Committee.
Bouchon previously served as Senior Vice President of New Business and Product Concepts at Moderna Therapeutics, where he led new business concept activities. In that role, he founded, financed and managed start-up companies that centered on human, animal and plant diseases. Prior to Moderna, he held a variety of roles with Bayer AG, including leading the Bayer HealthCare subgroup covering pharmaceuticals, consumer and animal health products and medical devices. Bouchon received his undergraduate degree in biochemistry, organic chemistry and immunology from Eberhard Karls University in Tübingen, Germany, and his doctorate from Tübingen.